Home / ALDH5A1 Knockout Cell Lines

ALDH5A1 Knockout Cell Lines

Gene: ALDH5A1

Official Full Name: aldehyde dehydrogenase 5 family member A1provided by HGNC

Gene Summary: This protein belongs to the aldehyde dehydrogenase family of proteins. This gene encodes a mitochondrial NAD(+)-dependent succinic semialdehyde dehydrogenase. A deficiency of this enzyme, known as 4-hydroxybutyricaciduria, is a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA). In response to the defect, physiologic fluids from patients accumulate GHB, a compound with numerous neuromodulatory properties. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00090 ALDH5A1 Knockout cell line (Huh-7) Human ALDH5A1 1:2~1:3 Negative Online Inquiry
KO06155 ALDH5A1 Knockout cell line (HeLa) Human ALDH5A1 1:3~1:6 Negative Online Inquiry
KO06156 ALDH5A1 Knockout cell line (HCT 116) Human ALDH5A1 1:2~1:4 Negative Online Inquiry
KO06157 ALDH5A1 Knockout cell line (HEK293) Human ALDH5A1 1:3~1:6 Negative Online Inquiry
KO06158 ALDH5A1 Knockout cell line (A549) Human ALDH5A1 1:3~1:4 Negative Online Inquiry

Background

ALDH5A1 Gene Knockout Cell Lines are specially engineered cellular models that have had the ALDH5A1 gene, which encodes the mitochondrial enzyme aldehyde dehydrogenase 5 family member A1, completely inactivated. This specific knockout allows researchers to study the gene's biological functions and the resulting metabolic consequences in a controlled environment. The ALDH5A1 enzyme plays a crucial role in the metabolism of gamma-aminobutyric acid (GABA), as well as in the detoxification of harmful aldehydes. By inhibiting this gene, researchers can elucidate pathways involved in neurological functions and investigate the implications of ALDH5A1 deficiency, particularly in disorders such as epilepsy and neurodegenerative diseases.

The key mechanism involves genetic alteration, where techniques like CRISPR/Cas9 or homologous recombination have been employed to disrupt the gene of interest. This precise alteration leads to a targeted study of altered metabolic pathways, enabling scientists to explore the roles and impacts of ALDH5A1 in various biochemical contexts. The study of these knockout cell lines is vital for advancing our understanding of metabolic disorders and for the development of targeted treatments.

In both research and clinical settings, ALDH5A1 Gene Knockout Cell Lines provide a unique platform for drug discovery, toxicity testing, and the investigation of genetic interactions. Their specialized design empowers researchers to exploit the specific biological insights that emerge from the loss of ALDH5A1 function, which may not be achievable through traditional models.

What sets these cell lines apart from other genetic models is their specificity and precision. Unlike general knockouts or less targeted gene editing methods, these ALDH5A1 knockout lines provide researchers with consistent and replicable models that yield high-fidelity data. Researchers and clinicians appreciate the reliability of this tool in dissecting the underlying mechanisms of disease processes and evaluating new therapeutic strategies.

Our company brings extensive expertise in genetic engineering and cellular biology, ensuring the delivery of high-quality, optimized products that meet the rigorous demands of modern research and clinical applications. Our commitment to excellence helps accelerate your research efforts and contributes to the advancement of scientific knowledge in the field.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.